The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...
Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...
Chronic obstructive pulmonary disease (COPD) presents a significant challenge for both patients and health care providers and discussions of effective management strategies took center stage at CHEST ...
The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...
Patients with COPD often experience chronic cough, difficulty breathing, and reduced lung function. While the respiratory disease is not curable, it can be treated and managed with medications ...
Right now the new inhaler propellant costs more ... for a propellant with 99.9% lower emissions for its COPD metered-dose maintenance inhaler, Breztri. The company plans to file for regulatory ...
With COPD, you have lung damage that worsens over time. Trelegy Ellipta does not come as a generic drug. Trelegy Ellipta comes in a dry powder inhaler. Each active ingredient in Trelegy Ellipta ...
President Joe Biden’s career-defining victories over Big Pharma — reforming Medicare to lower prices and capping inhaler costs for millions of Americans with lung disease — are facing an ...
One in 13 Australians over the age of 40 have chronic obstructive pulmonary disease (COPD), but alarmingly only half of them know they have ...
Cruises are a great way for travelers with COPD to see the world. Most large cruise lines allow passengers to travel with ...
Honeywell Solstice® Air can cut metered dose inhaler greenhouse gas emissions of up to 99.9% versus current propellants1 CHARLOTTE, N.C., October, 2024 – Honeywell (NASDAQ: HON) today announced a long ...
Early fall is when asthma flare-ups peak in the U.S., and a warming climate is bad news for sufferers: It means more ground-level ozone, a longer pollen season and more wildfire smoke — all ...